Dacmed 200mg Injection

Dacmed 200mg Injection

Prescription requiredRx Required

Salt Composition: Dacarbazine

Expiry Date: 01/2028

Special offer

Price on Request

Price on Request

Inclusive of all taxes

1 Injection

About The Product

Skin Cancer

Description

Dacmed 200mg Injection belongs to the category of anticancer medicines. It is used in the treatment of skin cancer that has spread to other body parts, and Hodgkin's disease (cancer that affects the lymphatic system). The active ingredient of the Dacmed 200mg is Dacarbazine, which belongs to the drug class of alkylating agents.


It is administered as an injection by an experienced nurse or medical professional. Dacmed Injection works by killing the cancer cells, thereby reducing the size of the tumor. In this way, it prevents cancer cells from spreading to other parts of the body. The doctor decides the required dosage and duration of the medicine.


Uses

  • Skin cancer
  • Hodgkin's lymphoma

Side Effects

The human body shows undesired symptoms after taking Dacmed 200mg Injection. Usually, they disappear with time as the body adjusts to the medicine. These side effects don't need special medical attention. It is advised to consult your doctor if these symptoms become unmanageable.

Some of the common side effects are mentioned below:

  • Low levels of RBC, WBC and platelets in blood.
  • Loss of appetite
  • Nausea, vomiting
  • Hair loss
  • Skin reactions

Serious

  • Sore throat or high temperature indicating infection
  • Unusual bleeding or bruising
  • Severe vomiting or diarrhea
  • Extreme tiredness
  • Severe allergic reaction, characterized by swelling of hands, feet, ankles, face, lips, mouth or throat; rashes or giddiness.
  • Headache, vision problems, fits, confusion, lethargy or numbness of face
  • Severe liver problems

How To Use

  • Dacmed 200mg Injection is a prescription-based anticancer drug. It is advised to take this injection after consulting your healthcare expert.
  • This medicine should be given intravenously by an experienced nurse or doctor. Please do not self-administer.

How It Works

  • The active ingredient of the Dacmed 200mg Injection is Dacarbazine, which belongs to the drug class of alkylating agents that works by alkylation. It inhibits DNA synthesis, which disturbs the normal functioning of DNA.
  • This process arrests the growth and proliferation of cancer cells, eventually leading to their death. In this way, it slows the progression of cancer.


Safety Advice

Alcohol
Avoid the consumption of alcohol while taking Dacmed 200mg Injection, as alcohol can decrease the effectiveness of the medicine as well as worsen the symptoms.
Pregnancy
Do not take Dacmed 200mg Injection without consulting the doctor in case of pregnancy, as it can be unsafe to take it during this period.
Breast Feeding
Breastfeeding women should discuss the potential risks and benefits of the Dacmed 200mg Injection with their healthcare provider before starting treatment.
Driving
Dacmed 200mg Injection may cause side effects such as dizziness or lack of concentration, which could affect your ability to drive. So it's better to avoid driving.
Kidney
Share your medical history with the doctor before starting the Dacmed 200mg Injection. Do not take it without consulting a doctor if you have any kidney related issue.
Liver
Share your medical history with the doctor before starting the Dacmed 200mg Injection. Do not take it without consulting a doctor if you have any liver related issue.

FAQs

It is advised to keep Dacmed 200mg Injection away from any kind of light during storage and administration.

While coming in contact with light, it becomes unstable and its effectiveness also gets reduced.

References

  • Hafeez, A., & Kazmi, I. (2017). Dacarbazine nanoparticle topical delivery system for the treatment of melanoma. Scientific reports, 7(1), 16517. https://www.nature.com/articles/s41598-017-16878-1
  • Ugurel, S., Paschen, A., & Becker, J. C. (2013). Dacarbazine in melanoma: from a chemotherapeutic drug to an immunomodulating agent. Journal of Investigative Dermatology, 133(2), 289-292. https://pubmed.ncbi.nlm.nih.gov/23318786/
  • Cocconi, G., Bella, M., Calabresi, F., Tonato, M., Canaletti, R., Boni, C., ... & Bacchi, M. (1992). Treatment of metastatic malignant melanoma with dacarbazine plus tamoxifen. New England Journal of Medicine, 327(8), 516-523. https://pubmed.ncbi.nlm.nih.gov/1635566/
  • Eggermont, A. M., & Kirkwood, J. M. (2004). Re-evaluating the role of dacarbazine in metastatic melanoma: what have we learned in 30 years?. European journal of cancer, 40(12), 1825-1836. https://pubmed.ncbi.nlm.nih.gov/15288283/
  • Reid, J. M., Kuffel, M. J., Miller, J. K., Rios, R., & Ames, M. M. (1999). Metabolic activation of dacarbazine by human cytochromes P450: the role of CYP1A1, CYP1A2, and CYP2E1. Clinical Cancer Research, 5(8), 2192-2197.    https://pubmed.ncbi.nlm.nih.gov/10473105/

i
Trust & safety

Medical Disclaimer

Accurate, reviewed information to support informed healthcare decisions

For informational purposes only
Not a substitute for professional medical advice
Consult your doctor for diagnosis and treatment

Magicine's primary objective is to ensure that its customers receive accurate, genuine, and trustworthy information reviewed by medical experts.

The content on this website has been produced solely for informational purposes. This is not intended to take the place of medical advice and care provided by a licensed professional, though.

This information may not include all potential side effects, warnings, and details about specific lab tests, medications, and medical conditions. Please ask your doctor any questions you may have about any drug or disease.

Our goal is not to replace or substitute for the doctor-patient relationship, but to uphold and strengthen it.

Always follow advice from your doctor, pharmacist, or other licensed healthcare professional before starting, stopping, or changing any medicine or treatment.
Magicine PharmacopyCopyright 2026